Compare AA & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AA | FMS |
|---|---|---|
| Founded | 1888 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Aluminum | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9B | 14.2B |
| IPO Year | 2016 | N/A |
| Metric | AA | FMS |
|---|---|---|
| Price | $70.57 | $23.01 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 11 | 2 |
| Target Price | ★ $64.00 | $30.00 |
| AVG Volume (30 Days) | ★ 5.2M | 418.9K |
| Earning Date | 04-16-2026 | 05-05-2026 |
| Dividend Yield | 0.56% | ★ 2.46% |
| EPS Growth | ★ 1580.77 | N/A |
| EPS | ★ 4.37 | N/A |
| Revenue | ★ $12,831,000,000.00 | N/A |
| Revenue This Year | $14.19 | $0.45 |
| Revenue Next Year | N/A | $3.76 |
| P/E Ratio | $16.46 | ★ $15.62 |
| Revenue Growth | ★ 7.87 | N/A |
| 52 Week Low | $23.06 | $20.96 |
| 52 Week High | $75.70 | $30.46 |
| Indicator | AA | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 58.14 | 50.66 |
| Support Level | $55.54 | $22.50 |
| Resistance Level | N/A | $24.08 |
| Average True Range (ATR) | 2.80 | 0.36 |
| MACD | 0.47 | 0.12 |
| Stochastic Oscillator | 71.22 | 53.17 |
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is one of the world's largest bauxite miners and alumina refiners by production volume, but sits outside the top-10 aluminum producers, a list dominated by Chinese companies. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.